The present invention provides selective 5-HT
7
receptor antagonist compounds of Formula I and their use in the treatment of migraine:
where A is —C(H)═ or —N═ and R
1-7
are as defined herein.
The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine:
where A is —C(H)═ or —N═ and R1-7 are as defined herein.